AHE Adheris Health Limited
Healthcare · Health Information Services
· website
$0.01
52wk 0.01 – 0.04
Overall
33.5
Value
100.0
Growth
49.5
Health
0.0
Quality
0.0
Momentum
1.4
Dividend
—
Price
About Adheris Health Limited
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in the United States. The company offers THRiV, a patient engagement platform, which transforms the patient experience by harnessing predictive modeling and precision segmentation. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | 8.3% |
| 1 month | -7.1% |
| 3 months | -13.3% |
| 6 months | -35.0% |
| 1 year | -69.0% |
| 3 years | -93.5% |
Risk
| Volatility (1y ann.) | 86.0% |
| Beta vs ASX 200 | 0.35 |
| Sharpe (1y) | -0.97 |
| VaR 95% (1-day) | -10.0% |
| Max drawdown (1y) | -71.4% |
| Off 1-year high | -69.0% |
Technicals
| RSI(14) | 50 |
| vs 50DMA | -11.6% |
| vs 200DMA | -28.3% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
100.0
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth
49.5
Revenue growth (1y)
99
Revenue CAGR (3y)
—
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health
0.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
0
Debt / Equity
—
Quality (Profitability & Cash Flow)
0.0
Return on equity
—
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
1.4
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
6
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$8.29M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.03
Dividend yield
—
Payout ratio
0.0%
Beta
1.06
EV / EBITDA
0.07
Price / Book
-3.25
ROE
—
Operating margin
-47.6%
Net margin
-12.7%
Total cash
$9.53M
Total debt
$131,743
Current ratio
0.76
Debt / Equity
—
Free cash flow
$11.96M
Avg volume
435,626
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.10
- Free cash flow—
- Net debt—